Vas Narasimhan, Novartis CEO (Thibault Camus/AP Images)
Novartis' first attempt to replicate a stunning cancer result falls flat
A decade ago, Novartis launched a 10,000-person trial to try to turn a rare disease drug into the next heart disease blockbuster. In 2017, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
